Peptara sells research-grade compounds with a published Certificate of Analysis, not branded prescription products
I personally had to stop taking the Lipo Burn as it gave me nausea
High Fever and Severe Symptoms Fever above 103F (39.4C), severe body aches, extreme fatigue, or difficulty breathing warrant pausing your medication and seeking medical care
By Product: Ozempic dominates, Tirzepatide products growing fastest Ozempic (semaglutide 0.5mg/1mg/2mg weekly subcutaneous injection) dominated the GLP-1 receptor agonist market with approximately 35.12% market share in 2025, driven by its combination of robust clinical efficacy data, early market entry, broad diabetes label, established prescriber relationships, and expanded off-label use for weight management before Wegovy's commercial scale-up
This flexibility means more people get timely access to a life-changing treatment